These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fibronectin assays and their clinical application: a review. Boughton BJ Cell Biochem Funct; 1985 Apr; 3(2):79-90. PubMed ID: 3915233 [TBL] [Abstract][Full Text] [Related]
3. [Review. The intensive medical care relevance of plasma fibronectin]. Lundsgaard-Hansen P; Doran JE; Rubli E Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):435-45. PubMed ID: 2431963 [TBL] [Abstract][Full Text] [Related]
4. Fibronectin (cold-insoluble globulin): role in defence. Vaheri A Schweiz Med Wochenschr; 1980 Oct; 110(40):1437-40. PubMed ID: 7025190 [TBL] [Abstract][Full Text] [Related]
5. Amplification of the opsonic activity of fibronectin by a plasma factor lacking gelatin affinity. Blumenstock FA; Saba TM; Cardarelli PM; Cho E J Reticuloendothel Soc; 1983 Jan; 33(1):21-33. PubMed ID: 6834358 [TBL] [Abstract][Full Text] [Related]
6. Clinical use of fibronectin in critically ill patients. Grossman JE Prog Clin Biol Res; 1989; 299():157-67. PubMed ID: 2657787 [No Abstract] [Full Text] [Related]
7. [The dependence of serum opsonic activity on fibronectin and alpha- 1 acid glycoprotein levels in children with burns]. Melezyńska-Matej M; Koziełł J; Tołkacz M; Czernik J; Grzybek-Hryncewicz K Pediatr Pol; 1996 Jun; 71(6):511-6. PubMed ID: 8756769 [TBL] [Abstract][Full Text] [Related]
8. [Fibronectin--an important factor of nonspecific body defense]. Markevych VE; Romaniuk OK; Pylypets' IV Lik Sprava; 2003; (1):13-7. PubMed ID: 12712600 [TBL] [Abstract][Full Text] [Related]
9. Fibronectin and wound healing. Grinnell F J Cell Biochem; 1984; 26(2):107-16. PubMed ID: 6084665 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of particulate activators. Czop JK; Kadish JL; Zepf DM; Austen KF J Immunol; 1985 Mar; 134(3):1844-50. PubMed ID: 3968434 [TBL] [Abstract][Full Text] [Related]
11. Plasma fibronectin: relevance for anesthesiology and intensive care. Doran JE; Lundsgaard-Hansen P; Rubli E Intensive Care Med; 1986; 12(5):340-9. PubMed ID: 3534038 [TBL] [Abstract][Full Text] [Related]
12. Current status of fibronectin in transfusion medicine: focus on clinical studies. Powell FS; Doran JE Vox Sang; 1991; 60(4):193-202. PubMed ID: 1926827 [TBL] [Abstract][Full Text] [Related]
13. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847]. Horisberger T; Harbarth S; Nadal D; Baenziger O; Fischer JE Crit Care; 2004 Dec; 8(6):R443-50. PubMed ID: 15566590 [TBL] [Abstract][Full Text] [Related]
14. Fibronectin in host defense: implications in the diagnosis, prophylaxis and therapy of infectious diseases. Yang KD; Bohnsack JF; Hill HR Pediatr Infect Dis J; 1993 Mar; 12(3):234-9. PubMed ID: 8451101 [No Abstract] [Full Text] [Related]
15. Decreased plasma fibronectin in neonatal sepsis. Gerdes JS; Yoder MC; Douglas SD; Polin RA Pediatrics; 1983 Dec; 72(6):877-81. PubMed ID: 6646931 [TBL] [Abstract][Full Text] [Related]
16. Humoral regulation of plasma opsonic fibronectin levels: its role in reticuloendothelial recovery after RE blockade. Roccario E; Saba TM; Cho E Adv Shock Res; 1981; 5():57-66. PubMed ID: 7304331 [TBL] [Abstract][Full Text] [Related]
17. Failure of fibronectin as an opsonin in the host defence system: a case of competitive self inhibition? Brown RA Lancet; 1983 Nov; 2(8358):1058-60. PubMed ID: 6138603 [TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]